首页> 外国专利> Glucocorticoid receptor agonist comprising derivatives of 2,2,4-trimethyl-6-phenyl-1,2-dihydroquinoline having a substituted oxy group

Glucocorticoid receptor agonist comprising derivatives of 2,2,4-trimethyl-6-phenyl-1,2-dihydroquinoline having a substituted oxy group

机译:糖皮质激素受体激动剂,其包含具有取代的氧基的2,2,4-三甲基-6-苯基-1,2-二氢喹啉的衍生物

摘要

A compound represented by formula (1) or a salt thereof, for use in the prevention or treatment of a disease: wherein R1 represents formulas (2a), (3a), (4a) or (5a); R2 represents - (CO) -R8, - (CO) O-R9, - (SO) -R10, - (SO2) -R11 or - (CO) NR12R13; R2-O- is substituent at position 4 or 5 of benzene ring A; R3 represents an alkyl group having 1 to 8 carbon atoms, preferably 1 to 6 carbon atoms; R4, R5, R6 or R7 represents a halogen atom, an alkyl group having 1 to 8 carbon atoms, preferably 1 to 6 carbon atoms, which may have one substituent, an alkenyl group having 2 to 8 carbon atoms, preferably 2 to 6 carbon atoms, an alkynyl group having 2 to 8 carbon atoms, preferably 2 to 6 carbon atoms, an alkoxy group having 1 to 8 carbon atoms, preferably of 1 to 6 carbon atoms, a nitro group or a formyl group m, n, p or q represents 0.1 or 2; in the case where m, n, p or q is 2, each R4, R5, R6 or R7 can be the same or different; R8, R9, R10 or R11 represents an alkyl group having 1 to 8 carbon atoms, preferably 1 to 6 carbon atoms, which may have one substituent, an alkenyl group having 2 to 8 carbon atoms, preferably from 2 to 6 carbon atoms, a cycloalkyl group having from 3 to 10 carbon atoms, preferably from 3 to 8 carbon atoms, an aryl group which may have one substituent or a heterocyclic group which may have one substituent; R12 and R13 may be the same or different and represent a hydrogen atom, an alkyl group having 1 to 8 carbon atoms, preferably 1 to 6 carbon atoms, which may have a substituent, an aryl group which may have a substituent or a heterocyclic group, wherein the disease is selected from the group consisting of an inflammatory eye disease and a dermatitis selected from the group consisting of acute eczema, subacute eczema, chronic eczema, contact dermatitis, nummular eczema, self-sensitization dermatitis, childhood eczema, chronic Vidal lichen simplex, seborrheic dermatitis, progressive palmar tyloid keratoderma, genital / anal eczema, eczema / dermatitis of the external ear canal or pinna, eczema / dermatitis around the nasal vestibule and fin of the nose, prurigo, urticaria, psoriasis, acrodermatitis, impetigo nerpetiformis, Reiter's syndrome, palmoplantar pustulosis, lichen planus, erythema, anaphyla purpura ctoid, Weber-Christian disease, oculocutaneous syndrome, Reynaud's disease, alopecia areata, pemphigus, Dühring's dermatitis herpetiformis, herpes zoster, erythroderma, lupus miliaris disseminates faciei, allergic angitis, pityriasis lichenoides et varioles, chronic and neonatal sclerema.
机译:用于预防或治疗疾病的由式(1)表示的化合物或其盐:其中R 1表示式(2a),(3a),(4a)或(5a); R2代表-(CO)-R8,-(CO)O-R9,-(SO)-R10,-(SO2)-R11或-(CO)NR12R13; R2-O-是苯环A的4或5位上的取代基; R 3表示具有1至8个碳原子,优选1至6个碳原子的烷基; R 4,R 5,R 6或R 7表示卤素原子,具有1至8个碳原子,优选1至6个碳原子的烷基,其可具有一个取代基,烯基具有2至8个碳原子,优选2至6个碳原子原子,具有2至8个碳原子,优选为2至6个碳原子的炔基,具有1至8个碳原子,优选为1至6个碳原子的烷氧基,硝基或甲酰基m,n,p或q代表0.1或2;在m,n,p或q为2的情况下,R 4,R 5,R 6或R 7可以相同或不同。 R 8,R 9,R 10或R 11表示可具有一个取代基的具有1至8个碳原子,优选1至6个碳原子的烷基,具有2至8个碳原子,优选2至6个碳原子的烯基,具有3至10个碳原子,优选3至8个碳原子的环烷基,可以具有一个取代基的芳基或可以具有一个取代基的杂环基; R 12和R 13可以相同或不同,表示氢原子,可以具有取代基的碳原子数为1〜8,优选为1〜6的烷基,可以具有取代基的芳基或杂环基。 ,其中疾病选自炎性眼病和皮炎,选自急性湿疹,亚急性湿疹,慢性湿疹,接触性皮炎,numemular湿疹,自敏性皮炎,儿童湿疹,慢性Vidal地衣单纯性,脂溢性皮炎,进行性手掌性角质性皮炎,生殖器/肛门湿疹,外耳道或耳廓的湿疹/皮炎,鼻前庭和鼻鳍周围的湿疹/皮炎,瘙痒,荨麻疹,牛皮癣,角膜炎,角膜炎,赖特氏综合症,掌plant脓疱病,扁平苔藓,红斑,过敏性紫癜,类韦伯基督教病,眼皮肤综合症,雷诺氏病,脱发斑疹伤寒,天疱疮,杜林疱疹样皮炎,带状疱疹,红皮病,纤毛狼疮散布着相,变应性血管炎,糠疹性糠疹,慢性和新生儿硬皮病。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号